1. Home
  2. ICLR vs ALGN Comparison

ICLR vs ALGN Comparison

Compare ICLR & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICLR
  • ALGN
  • Stock Information
  • Founded
  • ICLR 1990
  • ALGN 1997
  • Country
  • ICLR Ireland
  • ALGN United States
  • Employees
  • ICLR N/A
  • ALGN N/A
  • Industry
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • ALGN Industrial Specialties
  • Sector
  • ICLR Health Care
  • ALGN Health Care
  • Exchange
  • ICLR Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • ICLR 17.2B
  • ALGN 16.5B
  • IPO Year
  • ICLR 1998
  • ALGN N/A
  • Fundamental
  • Price
  • ICLR $205.07
  • ALGN $228.00
  • Analyst Decision
  • ICLR Strong Buy
  • ALGN Hold
  • Analyst Count
  • ICLR 12
  • ALGN 10
  • Target Price
  • ICLR $284.82
  • ALGN $265.22
  • AVG Volume (30 Days)
  • ICLR 910.7K
  • ALGN 659.4K
  • Earning Date
  • ICLR 02-19-2025
  • ALGN 02-05-2025
  • Dividend Yield
  • ICLR N/A
  • ALGN N/A
  • EPS Growth
  • ICLR 44.49
  • ALGN 24.62
  • EPS
  • ICLR 8.99
  • ALGN 5.86
  • Revenue
  • ICLR $8,306,823,000.00
  • ALGN $3,960,519,000.00
  • Revenue This Year
  • ICLR $3.99
  • ALGN $5.72
  • Revenue Next Year
  • ICLR $2.19
  • ALGN $6.22
  • P/E Ratio
  • ICLR $22.04
  • ALGN $38.24
  • Revenue Growth
  • ICLR 3.63
  • ALGN 4.03
  • 52 Week Low
  • ICLR $183.38
  • ALGN $196.09
  • 52 Week High
  • ICLR $347.72
  • ALGN $335.40
  • Technical
  • Relative Strength Index (RSI)
  • ICLR 44.37
  • ALGN 59.75
  • Support Level
  • ICLR $196.50
  • ALGN $213.54
  • Resistance Level
  • ICLR $228.29
  • ALGN $226.36
  • Average True Range (ATR)
  • ICLR 6.79
  • ALGN 6.21
  • MACD
  • ICLR -1.10
  • ALGN 2.01
  • Stochastic Oscillator
  • ICLR 26.96
  • ALGN 91.32

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: